BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 12, 2008
View Archived Issues
Pain Therapeutics, King Tumble On FDA's Remoxy Rejection
Shares of Pain Therapeutics Inc. plunged 21 percent Thursday after the San Mateo, Calif.-based firm said it received a complete response letter from the FDA for Remoxy, a controlled-release formulation of oxycodone. (BioWorld Today)
Read More
Acusphere Hits Rock Bottom on Negative Panel Vote on Imagify
Read More
Infinity Takes Back HSP90 in Terminated AstraZeneca Deal
Read More
Vivus Hits Endpoints in First Qnexa Phase III Obesity Trial
Read More
Salix Bowel Cleansing Products Get FDA Black-Box Warning
Read More
Other News To Note
Read More
Clinic Roundup
Read More